



|
|
|
ABIC Foundation Board of Directors
2011
 |
|
Jerome Konecsni - Saskatoon, SK, Canada
Chair – ABIC Foundation
Mr. Konecsni, Director General of the Plant
Biotechnology Institute (PBI) of the National Research
Council, is actively engaged in the biotech industry.
His extensive management experience and involvement in
the biotech community has created many long-lasting,
collaborative relationships, alliances, and strategic
partnerships. Prior to joining PBI, Jerome was the
President and CEO of Genome Prairie and the Vice
President of Corporate Development at the Saskatchewan
biotech firm, Bioriginal Food & Science Corp.
As CEO of Genome Prairie, he re-located the
corporation from Calgary to Saskatchewan and set up a
branch office in Manitoba. At Bioriginal, he was
responsible for the research activities, the
management of Bioriginal’s intellectual property
portfolio and had additional responsibilities in
research, product development, marketing, quality, and
human resources. His previous experience includes the
position of Vice President of Agricultural
Biotechnology and Vice President of Corporate Services
at the Saskatchewan Research Council. Jerome possesses
a diverse background and a broad range of expertise in
marketing, public relations, business development,
human resource management, and general administration.
He received his post-secondary education at the
University of Saskatchewan where he obtained his BA (Honours),
BEd and MA degrees.
|
|
|
|
|
 |
|
Wilf
Keller – Saskatoon, SK, Canada
As President and CEO, Wilf Keller oversees
Ag-West Bio’s mandate to support the growth and development of a vibrant
agriculture-based bioeconomy in Saskatchewan.
Wilf was born in Melville, Saskatchewan. He attended the University of
Saskatchewan, receiving a doctoral degree with specialization in Crop Science in
1972. He studied as a postdoctoral scientist in the Max-Planck Institut für
Biologie, in Tubingen, Germany. Wilf was employed as a Research Scientist with
the Research Branch of Agriculture Canada in Ottawa from 1973-89. During this
period he pursued research on cell genetics of selected Canadian crops and he
contributed to the establishment of a plant biotechnology research program which
he chaired from 1980-89. In 1990, he accepted a position with the Plant
Biotechnology Institute (PBI) of the National Research Council of Canada in
Saskatoon and served as Group Leader for canola biotechnology research and Head
of the Transgenic Plant Centre until 1999 when he assumed the position of
Research Director. In July 2007, Wilf assumed the role of Acting Director
General, PBI for a period of one year.
Wilf has been actively involved in the development and application of
biotechnologies for the genetic modification of crops, particularly canola. He
has collaborated with numerous government, university and industry groups and
has provided training for researchers in plant biotechnology. He has led major
research initiatives on the application of genomics in canola improvement, the
development of industrial bioproducts from vegetable oils, and production of
bioactive natural products in plants for enhanced human health and quality of
life. He has given many presentations and lectures on aspects of biotechnology
including public awareness and public education aspects of this emerging field.
|
|
|
|
|
 |
|
Roger Kemble - Research Triangle Park, North Carolina,
USA
Dr. Kemble is President of Syngenta
Biotechnology, Inc. (SBI), Research Triangle Park, NC,
USA. SBI is part of Syngenta AG, the leading global
agribusiness company. Within the parent company,
Dr.Kemble fulfills the role of Global Head of Crop
Genetics Research. Following a PhD from King's
College, University of London, and a Postdoctoral
Research Fellowship at the Plant Breeding Institute,
Cambridge, Dr. Kemble moved to North America with
ensuing tenures at University of Florida, Kansas State
University, Allelix Inc. (in Canada) and Pioneer
Hi-Bred International, Inc., prior to joining Syngenta
in 2002. |
|
|
|
|
 |
|
Malcolm D. Devine
-
Saskatoon, SK, Canada
Malcolm Devine is Principal at bioQED Strategic
Consultants Ltd., a boutique consultancy
specializing in strategic, R&D and business planning
in the agriculture and ag biotechnology spaces.
Dr. Devine has an extensive background in agricultural
R&D and business development, in both the public and
private sectors. From 2006 to early 2010 he served
as Vice President, Agricultural Crops with
Performance Plants Inc., a Canadian plant
biotechnology company focused on developing novel,
high-value traits for crops. Dr. Devine was
responsible for demonstrating technology proof of
concept in crops and for licensing PPI’s IP to seed
companies internationally. Prior to joining
Performance Plants, Dr.Devine served two years
(2004-2006) as Research Director at the National
Research Council Plant Biotechnology Institute in
Saskatoon.
From 1998-2004, Dr.Devine held a series of
positions with AgrEvo Canada Inc, Aventis
CropScience Inc. and Bayer BioScience NV. He managed
the Canadian biotechnology research group for AgrEvo
and Aventis CropScience from 1998-2001, and from
2001-2004 was based in Gent, Belgium, serving as
Head of Technology Identification, Assessment and
Acquisition for BioScience division of Aventis
CropScience, and later Bayer CropScience. This group
was responsible for coordinating technology
evaluation, licensing agreements and collaborations
in support of BioScience research.
From 1987 to 1998 Dr.Devine held a faculty position
in the Department of Plant Sciences at the
University of Saskatchewan, and served as Department
Head from 1994-1998.
Dr.Devine holds a B.Sc. from Glasgow University
(Scotland), and graduate degrees in Crop Science
from the University of Guelph. |
|
|
|
|
 |
|
Art
Froehlich – Calgary, Alberta, Canada
Mr. Froehlich is a Partner in AdFarm, one of North Americas largest
Agriculture Communications Companies. AdFarm, with offices in Calgary AB,
Winnipeg MB, Guelph ON, Fargo ND, and Kansas City, MO works with many world
leading agricultural organizations providing marketing, communications, business
planning and consulting services. In addition to his role at AdFarm, Mr.
Froehlich is the Chair of Genome Alberta and the Alberta Agricultural Research
Institute. Mr. Froehlich also sits on the Boards of many Private and Public
sector organizations including Prince Rupert Grain, Canterra Seeds, ATB
Financial, Alberta Science and Research Authority, Science Alberta Foundation,
Alberta Life Science Institute and the Alberta Heritage Foundation for Medical
Research. Mr. Froehlich was also Co-Chair of the ABIC 2007 Conference held in
Calgary.
Mr. Froehlich holds a B.Sc. (Agriculture) from the University of Saskatchewan
and an Executive MBA from the University of Pennsylvania’s Wharton School of
Business. His professional career has included Sr. Executive positions with
Hoechst Canada Inc., Alberta Wheat Pool and Westcan Malting. He has mentored
young Entrepreneurs in the Business Development Bank of Canada “Young
Entrepreneurs Program” and continues to mentor young Agrologists for the Alberta
Institute of Agrologists. Mr. Froehlich is still active in primary agriculture
raising registered Red Angus cattle, grains and oilseeds on his farm in
Saskatchewan. |
|
|
|
|
 |
|
Peter Welters - Cologne, Germany
Dr. Welters is CEO of Phytowelt GreenTechnologies
GmbH, a fusion of GreenTec and Phytowelt, located in
Nettetal (head office) and Cologne (R&D). The
company offers laboratory and know-how services in
agbiotech, e.g. somatic hybridization, tissue
culture, marker technologies, contract studies and
project coordination. After studying chemistry,
biochemistry and food chemistry in Germany, Peter
spent four years at the Max Planck Institute for
Plant Breeding Research, there obtaining his Diploma
and PhD. He worked in Jeff Schell’s group on
promoter control in legume/rhizobia nitrogen-fixing
symbioses. After three years at the University of
California, San Diego, in the laboratories of
Maarten Chrispeels and Scott EMr., researching
protein transport regulation in plants and yeasts,
he was chosen as head of the Production of
Pharmaceutical Proteins in Plants project in Rouen,
France. Dr.Welters' innovative ideas led to the
foundation of Biotechnology and Molecular Biology,
which became Phytowelt GmbH in 1998. Four years
later, he became CEO of GreenTec GmbH, a spin-off
company of the Max Planck Institute, founded by
Schell, Klaus Hahlbrock, Frederico Salamini, and
Heinz Saedler. Phytowelt GreenTechnologies GmbH then
was founded in January 2006. |
|
|
|
|
 |
|
Brigitte Weston - Durham, NC, USA
Dr. Weston is the Global Development Manager,
Herbicide Tolerant Oilseeds and Wheat, for BASF
Plant Science L.L.C. Brigitte joined BASF Plant
Science in this capacity in October 2005.
Dr.Weston was formerly with Bayer Crop Science,
Inc. in the position of Global Development Manager,
Canola and OSR. Brigitte earned her PhD from the
University of Saskatchewan and her M.Sc. and B.Sc.
from Carleton University in Ottawa. Prior to moving
into her previous position with Bayer Crop Science
in 2002, she worked as the Elite Event Coordinator,
Canola/OSR for Plant Genetic SysteMs. / Aventis CropScience based in Belgium (1997 - 2002). From
1991 until 1997, Brigitte was a research associate
for AgrEvo Canada and Hoechst Canada in Saskatoon
and participated in the development of Liberty Link
canola, the first GM-canola crop registered in North
America. At BASF, Brigitte coordinates global
development activities for new herbicide tolerant
traits in canola / OSR, sunflower and wheat until
regulatory approval is attained and until the trait
is technically released to BASF’s marketing
organization. |
|
|
|
|
 |
|
Clive James
In 1990, Dr. James founded ISAAA, a not-for-profit
charitable organization, established to facilitate
the sharing of knowledge and the acquisition and
transfer of crop biotechnology applications from the
industrial countries, for the benefit of
resource-poor farmers in the developing world. The
mission of ISAAA is to alleviate hunger and poverty
in the developing countries.
An agricultural scientist, Dr. James received his
formal training in the UK with a first degree in
agriculture from the University of Wales, followed
by a PhD from Cambridge University. Prior to his
association with ISAAA he was Deputy Director
General at the International Maize and Wheat
Improvement Center (CIMMYT) in Mexico, where he
worked with the late Dr. Norman Borlaug, the Nobel
Peace Prize laureate, who was the founding patron of
ISAAA. The last twenty-five years have been spent
living and/or working in the developing countries of
Asia, Latin America, and Africa and devoted to
agricultural research & development issues, and crop
biotechnology. He has served, as Senior Agricultural
Adviser to the Canadian Bilateral Aid Agency (CIDA),
the Food and Agricultural Organization (FAO) of the
United Nations and has consulted for many
international development agencies including United
Nations Development Programme (UNDP), the World
Bank, and many international philanthropic
foundations, including the Rockefeller and Hitachi
Foundations.
Dr. James has published internationally-recognized
Annual Reviews on the Global Status of GM crops, and
their contribution to global food, feed, fiber, and
fuel security, since 1996 when GM crops were first
commercialized. |
|
|
|
|
 |
|
Jennifer Thomson- South Africa
Co-Chair ABIC 2011, Johannesburg, South Africa
September 6 - 9
Jennifer has a BSc in Zoology from the University of
Cape Town (UCT), an MA in Genetics from Cambridge
University and a PhD in Microbiology from Rhodes
University, South Africa. After a post-doctoral
fellowship at Harvard, she was a Lecturer and Assoc.
Professor at the University of the Witwatersrand and
then started and ran the Laboratory for Molecular
and Cell Biology for the Council for Scientific and
Industrial Research. She was appointed Professor and
Head of the Department of Microbiology at UCT in
1988, a position she held for 12 years. She won the
L’Oreal/UNESCO prize for Women in Science for Africa
in 2004 and was awarded an Honorary Doctorate from
the Sorbonne University, Paris in 2005. Her main
research interests are the development of maize
resistant to the African endemic Maize streak virus
and tolerant to drought. She has published two books
on the subject of Genetically Modified Organisms:
Genes for Africa and Seeds for the Future. She is
currently Emeritus Professor in the Department of
Molecular and Cell Biology at UCT.
|
|
|
|
|
 |
|
Diran Makinde - South Africa
Co-Chair ABIC 2011, Johannesburg, South Africa
September 6 – 9
Diran Makinde is the Director, NEPAD Planning and
Coordinating Agency (A Program of African Union)
African Biosafety Network of Expertise (ABNE) based
in Ouagadougou, Burkina Faso. He is the immediate
past Director of the NEPAD West African Biosciences
Network in Dakar, Senegal. He earned the degrees of
Doctor of Veterinary Medicine and a PhD in
Veterinary Physiology from the University of Ibadan,
Nigeria, and a postgraduate Diploma in
Neurophysiology from the University of Edinburgh,
Scotland. Prior to his current appointment, he was
in academia from 1978-2007 with teaching experience
from the universities of Ibadan (Nigeria), Zimbabwe
and Venda (South Africa) where he served as Dean,
School of Agriculture, Forestry and Rural
Development (1997-2001). His research interests
reside in the field of gastrointestinal physiology
of monogastrics which brought him into the area of
biosafety. He is well published and was a C-rated
scientist as evaluated (1998) by the South Africa
National Research Foundation. He is a member, from
inception, and former President and Board of
Director, AfricaBio, a non-profit making
biotechnology stakeholders association based in
South Africa and was in-charge of biosafety
regulatory issues. |
|
|
|
|
 |
|
NZ BIO - New Zealand
Chair ABIC 2012,
Rotorua, New Zealand
September 2 -6, 2012
Michelle joined NZ BIO from New
Zealand Trade and Enterprise's investment team where
she specialized in attracting foreign investment
into New Zealand's Biotechnology and Food & Beverage
sectors. She has worked with major multinational
corporations, international biotechnology companies
and venture capital funds to attract investment and
partnerships into New Zealand companies.
Michelle’s experience includes
working as a scientist to identify potential drug
targets for the common fungal pathogen Candida
albicans. She has also worked in environmental
consultancy in Auckland and lectured in
environmental engineering at Manukau Institute of
Technology (MIT).
Within government she has worked at
the Health Research Council on the creation of
cross-government research initiatives to address a
range of human health and environmental issues. She
has held a range of positions within NZTE and worked
in Auckland, London and New York. Michelle has an
Honours degree in Biochemistry from the University
of Otago where she was awarded the Proudfoot
Scholarship in Experimental Science and the Edson
Prize in Biochemistry. She holds a PhD in Protein
Biochemistry from Massey University. |
|
|
|
|
 |
|
Robert Rennie - Vancouver, BC, Canada
Co-Chair ABIC 2013, Calgary, AB, Canada
September 15 – 18
Dr. Rennie joined Spur Ventures as a Director and
Chief Executive Officer in March of 2005 and was
promoted to President & CEO in 2006. He was formerly
with Agrium Inc. where he was Vice President
International and Vice President Corporate
Relations. As VP International he was responsible
for starting Agrium’s wholesale fertilizer and
growing their retail agricultural business in
Argentina. As VP Corporate Relations he represented
Agrium in its various political and environmental
dealings with the US, Canadian and Argentine
governments. Dr. Rennie earned a PhD from the
University of Minnesota in soil microbiology, a M.S.
from Université Laval in soil chemistry and a B.S.A.
(Honours) from the University of Saskatchewan in
soil science. He has more than 25 years of
experience in international agriculture and
agriculture R&D serving as a scientist with
Agriculture Canada and previously as an Officer with
the International Atomic Energy Agency and Food and
Agriculture Organizations of the United Nations.
Dr. Rennie is Vice Chairman of the Agriculture Committee
of the International Fertilizer Industry Association
(IFA) and Co-Chairman of the Alberta Life Sciences
Institute and a member of the Board of the Alberta
Science and Research Authority. Spur Ventures is a
Vancouver-based junior fertilizer company which
trades on the TSX in Canada and OTC in the USA under
the symbol “SVU.” It is developing two rich
phosphate rock deposits near Yichang City, Hubei
Province, PRC which will result in the production of
1.2 million tonnes of compound fertilizer
production. When completed Spur will market over one
million tonnes of phosphate fertilizers, and have a
small trading company and generate annual revenues
in excess of $US 250 million. Dr. Rennie is fluent
in English, French, Spanish and German and includes
travel, long-distance running and reading in his
hobbies.
|
|
|
|
|
 |
|
Rick Smith – Calgary, AB, Canada
Co-Chair ABIC 2013, Calgary, AB, Canada
September 15 – 18
Rick Smith is Chairman of the Board of SemBioSys
Genetics Inc. (TSX:SBS); Director of Commercial
Solutions Inc. (TSX:CSA), Co-Chair of BioAlberta and
Director of AVAC Ltd. He has significant senior
management experience in the life sciences area,
including human pharmaceuticals, animal health and
plant sciences with Eli Lilly and Company, as well
as several commercialization initiatives in plant
biotechnology. He retired at the end of 2005 as
President and CEO of Dow AgroSciences Canada Inc.,
a wholly owned subsidiary of the Dow Chemical
Company. |
|